Katie Carpenter, Chief of Staff & Senior Director, Strategy, Ear, Nose, and Throat Division, Medtronic

Katie Carpenter, Chief of Staff & Senior Director, Strategy, Ear, Nose, and Throat Division, MedtronicKatie Carpenter, Chief of Staff & Senior Director, Strategy for the Ear, Nose, and Throat division at Medtronic, spoke with Invest: about Medtronic’s role in Jacksonville’s healthcare technology ecosystem, the launch of new ENT surgical solutions, and the growing importance of connected, data-enabled care. “Data-enabled surgical integration is a key aspect that we are seeing in ENT, as well as in broader healthcare,” Carpenter said.

What is your role at Medtronic, and how does the ENT division fit within the broader healthcare and technology landscape in Jacksonville?

I’ve spent the past 12 years with Medtronic’s ENT division, working across marketing and strategy before moving into my current role as Senior Director of Strategy and Chief of Staff. In this role, I focus on driving strategic alignment, strengthening execution, and enabling our leadership team to deliver on our growth and innovation priorities- all grounded in a patient-first mindset.

ENT is part of Medtronic’s Neuroscience portfolio, which ladders into the broader Medtronic enterprise. At Medtronic, our Mission is to alleviate pain, restore health, and extend life, and that Mission directly guides the work we do within ENT. Our vision is to be the global leader for innovative ENT solutions that improve outcomes, customer satisfaction, and access, always with a focus on putting patients at the center of everything we do.

From a Jacksonville perspective, we are an important part of the region’s healthcare and innovation ecosystem, bringing together surgical technology and clinical expertise to provide the best patient outcomes possible. More broadly, we operate at the intersection of healthcare and technology, contributing to Medtronic’s role as a global leader in medtech and helping transform how ENT conditions are treated around the world.

What role does Medtronic play in Jacksonville and Northeast Florida?

Medtronic has a long-standing presence in Jacksonville, dating back to the acquisition of Xomed Surgical in 1999. Today, Jacksonville serves as the global headquarters for our ENT division, making it a critical hub for innovation within Medtronic’s Neuroscience portfolio.

We are one of the region’s leading medical technology employers, with a 22-acre campus and more than 500 professionals supporting the full device lifecycle, 

As a medtech leader in the region, we also play an important role in attracting and developing top talent—both locally and nationally—helping to strengthen Jacksonville’s position as a growing hub for healthcare innovation.

What notable successes or strategic developments have most influenced the ENT division over the past year, or are underway?

Over the past year, one of the most significant areas of progress for our ENT division has been accelerating innovation and bringing new technologies to market. A key milestone has been the launch of our Stealth AXiS™ ENT surgical navigation system that supports both sinus and skull base procedures by enabling greater precision and confidence in complex cases. We’re now focused on partnering closely with surgeons through training and education to ensure they can fully leverage the technology in clinical practice.

Our Jacksonville campus plays a critical role in this effort. With our state-of-the-art training facilities, we bring physicians from around the world for hands-on experience.

In parallel, we’ve also introduced new product advancements such as our ApexCut™ blades, which deliver enhanced performance and precision in sinus surgery. 

Together, these launches reflect a broader strategic focus on delivering innovative and patient-centered solutions.

How important is the training component behind these product launches?

The training component is absolutely critical to the success of these launches. Our focus is on ensuring surgeons can confidently and effectively use it to improve patient outcomes.

Our Jacksonville facility is central to that effort. With state-of-the-art training labs that are in near-constant use, we host physicians from around the world for hands-on experience with our technologies in an immersive, world-class training environment.

What trends are shaping ENT and the broader healthcare technology sector? 

One of the most important trends shaping both ENT and the broader healthcare technology landscape is the shift toward fully integrated, data-enabled surgical ecosystems. Rather than standalone tools, the focus is increasingly on connecting technologies across the entire patient journey – before, during, and after a procedure – to drive better insights and outcomes.

Before surgery, these technologies enable more personalized planning by leveraging patient-specific data and advanced imaging. During the procedure, surgeons benefit from real-time guidance and feedback, improving precision and confidence in complex cases. Afterward, the ability to capture and analyze procedural data creates new opportunities to refine techniques, track outcomes, and continuously improve care.

This end-to-end integration reflects a broader move toward precision medicine and digital healthcare where data, connectivity, and advanced visualization come together to support better clinical decision-making and deliver more consistent, high-quality outcomes for patients

How is Medtronic leveraging predictive technologies and AI tools in ENT care?

We are actively investing in and expanding our AI capabilities across ENT. One example is the Touch Surgery™ ecosystem, which is one piece of our broader effort to build more connected, data-driven surgical solutions. Part of our AiBLE™ ENT smart ecosystem, the Touch Surgery™ is a cloud-connected video recording and live streaming platform that has intraoperative and postoperative AI-powered analytics today, and we will continue to grow its capabilities into the future.

We are still in the early stages, but we believe AI and advanced analytics will play an increasingly important role in helping surgeons deliver more personalized, precise care. The Touch Surgery™ ecosystem is a key part of that vision and an area where Medtronic is helping shape the future of intelligent surgery. Eventually, that system will be able to provide the surgeon with differentiated, data-informed surgical recommendations and insights for each patient.

How are you thinking about usability, measurable outcomes, and better patient outcomes as these technologies become more connected?

Right now, our focus today is on building the data-enabled foundation for the future of ENT care. As we generate more high-quality data, we’ll be able to develop deeper insights, better understand outcomes, and unlock new predictive capabilities.

At the same time, we’re creating an intelligent surgical ecosystem through AiBLE™ ENT. By connecting technologies across the surgical workflow, we’re helping streamline procedures, improve efficiency, and support greater precision in the operating room.

As these technologies become more connected and data-driven, we see opportunities to deliver more consistent outcomes for surgeons and better experiences for patients. That’s the long-term vision behind AiBLE™ ENT.

What challenges is the broader healthcare technology industry facing?

One of the defining challenges facing the healthcare technology industry is the growing financial and operational pressure on providers. Hospitals, in particular, are navigating escalating operational costs alongside persistent labor shortages, which are straining their ability to deliver care efficiently while maintaining profitability.

As a result, there is much greater scrutiny on how new technologies contribute to both clinical and economic value. It’s no longer enough to advance outcomes alone; solutions must also help improve workflow efficiency, reduce procedural complexity, and support care teams that are often operating with constrained staffing.

At the same time, we’re seeing an acceleration in the shift of procedures from hospitals to ambulatory surgery centers. In ENT, this trend has been underway for years, driven by both cost dynamics and the ability to deliver high-quality care in lower-acuity settings. When done appropriately, this transition can help reduce system costs, improve throughput, and create a more convenient experience for patients. 

Overall, these dynamics are pushing the industry to innovate differently, focusing not just on what’s clinically possible, but on what is practical and sustainable in real-world care environments. And from my perspective, that’s where the most meaningful innovation is happening right now

What priorities are you setting for the ENT division over the next three to five years?

Looking ahead over the next three to five years, we’re very focused on evolving ENT into a more connected, intelligent, and patient-centered ecosystem. What we consistently hear from surgeons is that they want technology that feels intuitive and seamlessly integrated into their workflow – something that works as simply and reliably as the technology they use in their everyday lives.

From my perspective, that’s what makes this moment so exciting. We’re building toward a fully connected surgical environment through platforms like AiBLE™ ENT, alongside integrated technologies such as Touch Surgery™ and our Stealth AXiS™ surgical navigation system. Together, these solutions are designed to bring meaningful data and insights into the surgical suite in a way that is actionable and easy to use.

Ultimately, our priority is to help surgeons work more efficiently, make more informed decisions, and deliver better experiences and outcomes for patients. And personally, that’s what I find most motivating – seeing how these innovations can translate into real impact in the operating room and, most importantly, for the patients we serve.

Is there anything else you would like to highlight? 

From an internal perspective, one area we’ve really prioritized is the use of AI and digital tools to help our teams work faster and more effectively. I’ve seen firsthand how these capabilities are improving collaboration across functions and helping us operate with greater speed and focus as an organization. Ultimately, that allows us to better support our customers and deliver for patients.

In addition, we’ve placed a strong emphasis on execution – how quickly and effectively we can bring innovation to market and scale it globally. It’s not just about having great technologies, but about ensuring we can translate those innovations into real impact for surgeons and patients at pace. That requires strong alignment across teams, clear priorities, and a disciplined operating model.

Taken together, those priorities – building digital capabilities internally and strengthening how we execute – are what enable us to stay responsive in a rapidly evolving environment and continue delivering meaningful, patient-centered innovation